AN INVESTIGATION ON THE ROLE OF PLASMA AND SERUM OPSONINS ON THE INTERNALIZATION OF BIODEGRADABLE POLY(D,L-LACTIC ACID) NANOPARTICLES BY HUMAN MONOCYTES

被引:106
作者
LEROUX, JC
DEJAEGHERE, F
ANNER, B
DOELKER, E
GURNY, R
机构
[1] UNIV GENEVA,SCH PHARM,CH-1211 GENEVA 4,SWITZERLAND
[2] UNIV GENEVA,DEPT MED,EXPTL CELL THERAPEUT LAB,CH-1211 GENEVA 4,SWITZERLAND
[3] UNIV GENEVA,DEPT PHARMACOL,CH-1211 GENEVA 4,SWITZERLAND
关键词
NANOPARTICLE; OPSONIZATION; FLOW CYTOMETRY; POLY(LACTIC ACID); POLYETHYLENE GLYCOL;
D O I
10.1016/0024-3205(95)00321-V
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
We demonstrate here that polyethylene glycol (PEG) 6,000 protects biodegradable poly(D,L-lactic acid) nanoparticles (PLA NP) from extensive uptake by monocytes in plasma. These results are in agreement with those previously obtained with PEG 20,000 which reduced the uptake of PLA NP by human monocytes in phosphate buffered saline and plasma, and prolonged the NP circulation time in vivo. The coating efficiency of PEG 6,000 and 20,000 was substantially decreased in serum. The difference between the uptake of plain and coated NP clearly reappeared for PEG 20,000-coated NP in heat inactivated serum and in IgG-depleted serum. We suggest that typical plasma proteins, heat labile serum proteins (e.g. complement components) and IgG are involved in the opsonization of plain and coated PLA NP. Other proteins previously found to adsorb onto these NP, namely albumin and apolipoprotein E, did not appear to directly influence the uptake process.
引用
收藏
页码:695 / 703
页数:9
相关论文
共 41 条
[1]   IN-VITRO EXTENDED-RELEASE PROPERTIES OF DRUG-LOADED POLY(DL-LACTIC ACID) NANOPARTICLES PRODUCED BY A SALTING-OUT PROCEDURE [J].
ALLEMANN, E ;
LEROUX, JC ;
GURNY, R ;
DOELKER, E .
PHARMACEUTICAL RESEARCH, 1993, 10 (12) :1732-1737
[2]   DISTRIBUTION, KINETICS AND ELIMINATION OF RADIOACTIVITY AFTER INTRAVENOUS AND INTRAMUSCULAR INJECTION OF C-14 SAVOXEPINE LOADED POLY(D,L-LACTIC ACID) NANOSPHERES TO RATS [J].
ALLEMANN, E ;
GURNY, R ;
DOELKER, E ;
SKINNER, FS ;
SCHUTZ, H .
JOURNAL OF CONTROLLED RELEASE, 1994, 29 (1-2) :97-104
[3]  
ALLEMANN E, 1993, EUR J PHARM BIOPHARM, V39, P173
[4]  
ALLEMANN E, 1993, EUR J PHARM BIOPHARM, V39, P13
[5]   PREPARATION OF AQUEOUS POLYMERIC NANODISPERSIONS BY A REVERSIBLE SALTING-OUT PROCESS - INFLUENCE OF PROCESS PARAMETERS ON PARTICLE-SIZE [J].
ALLEMANN, E ;
GURNY, R ;
DOELKER, E .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1992, 87 (1-3) :247-253
[6]   THE USE OF GLYCOLIPIDS AND HYDROPHILIC POLYMERS IN AVOIDING RAPID UPTAKE OF LIPOSOMES BY THE MONONUCLEAR PHAGOCYTE SYSTEM [J].
ALLEN, TM .
ADVANCED DRUG DELIVERY REVIEWS, 1994, 13 (03) :285-309
[7]   LARGE UNILAMELLAR LIPOSOMES WITH LOW UPTAKE INTO THE RETICULOENDOTHELIAL SYSTEM [J].
ALLEN, TM ;
CHONN, A .
FEBS LETTERS, 1987, 223 (01) :42-46
[8]  
ALLENMANN E, IN PRESS J PHARM PHA
[9]   BODY DISTRIBUTION OF FULLY BIODEGRADABLE [C-14] POLY(LACTIC ACID) NANOPARTICLES COATED WITH ALBUMIN AFTER PARENTERAL ADMINISTRATION TO RATS [J].
BAZILE, DV ;
ROPERT, C ;
HUVE, P ;
VERRECCHIA, T ;
MARLARD, M ;
FRYDMAN, A ;
VEILLARD, M ;
SPENLEHAUER, G .
BIOMATERIALS, 1992, 13 (15) :1093-1102
[10]   MOLECULAR MECHANISM OF THE LIPID VESICLE LONGEVITY INVIVO [J].
BLUME, G ;
CEVC, G .
BIOCHIMICA ET BIOPHYSICA ACTA, 1993, 1146 (02) :157-168